1-2 of 2
Jianyu Rao, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of Elacytarabine/Idarubicin As Second Course Remission-Induction in Patients with Acute Myeloid Leukemia Who Failed Cytarabine/Anthracycline

David A. Rizzieri, MD, Norbert Vey, MD, PhD, Xavier Thomas, MD, Françoise Huguet, Richard F Schlenk, MD, Jürgen Krauter, MD, Ph.D., Thomas Kindler, MD, Bjorn Gjertsen, MD, PhD, Igor W. Blau, Malin Johansen, Trygve Bergeland, Athos Gianella-Borradori, Tove Flem Jacobsen, Jianyu Rao, MD, Utz Krug
Journal: Blood
Blood (2012) 120 (21): 46.
https://doi.org/10.1182/blood.V120.21.46.46
Published: 2012
Journal Articles

A Phase II Study of Elacytarabine/Idarubicin As Second Course Remission-Induction in Patients with Acute Myeloid Leukemia Who Failed Cytarabine/Anthracycline, and Evaluation of the Impact of the Nucleoside Transporter hENT1 on Response

David A. Rizzieri, MD, Norbert Vey, MD, Richard F. Schlenk, MD, Xavier Thomas, MD, PhD, Françoise Huguet, MD, Bjorn Gjertsen, MD, PhD, Jürgen Krauter, Igor Wolfgang Blau, Malin Johansen, Athos Gianelli-Borradori, Tove Flem Jacobsen, Jianyu Rao, MD, Utz Krug, MD
Journal: Blood
Blood (2011) 118 (21): 1533.
https://doi.org/10.1182/blood.V118.21.1533.1533
Published: 2011